Case Study: Blockbuster Drug accelerates CAR T trial delivery with DSG eClinical and data management support

Blockbuster Drug launches CAR T study 2 weeks faster with Dsg

The pharmaceutical sponsor Blockbuster Drug was facing challenges in finding a single vendor to provide EDC, IRT, in-house data management, and a biostatistical team for their CAR T-cell therapy study. They needed a cohesive solution with a central point of contact and were concerned about build timelines and implementation.

DSG implemented its unified eCaselink platform and provided an experienced team with CAR T expertise. This solution enabled DSG to build the EDC and IRT systems two weeks faster than the proposed timeline, ensuring excellent data quality and timely database locks. The integrated support also contributed to an early submission, and the study was ultimately granted Breakthrough Therapy Designation by the FDA.